Department of Neurology, School of Medicine, Johns Hopkins University, 600 North Wolfe St. Phipps 446C, Baltimore, MD, 21287, USA.
Neurocrit Care. 2022 Apr;36(2):595-601. doi: 10.1007/s12028-021-01348-4. Epub 2021 Sep 27.
The 24-h head computed tomography (CT) scan following intravenous tissue plasminogen activator or mechanical thrombectomy (MT) is currently part of most acute stroke protocols. However, as evidence emerges regarding who is at highest risk for treatment complications, the utility of routine neuroimaging for all patients has become less clear.
Four hundred seventy-five patients presenting with acute ischemic stroke to Johns Hopkins Bayview Medical Center between 2004 and 2018 and treated with intravenous tissue plasminogen activator and/or MT were evaluated. Neuroimaging performed during the first 48 h of hospitalization was reviewed for edema, hemorrhagic transformation (HT), or other findings altering management. Early imaging (< 24 h), performed for neurologic deterioration, was compared with imaging performed per protocol (24 ± 6 h). Factors predictive of radiographically and clinically significant findings on per-protocol imaging were determined.
One hundred fifty-three patients (32%) underwent early imaging. These patients generally had more severe strokes. HT was found in 15% of cases. For the remaining patients (n = 322), imaging at 24 h impacted acute management for only 24 patients: resulting in emergent hemicraniectomy in 1 (0.3%) and leading to additional imaging to monitor asymptomatic HT or edema in 23 (7.1%). Advanced age, higher stroke severity, MT, and atrial fibrillation were associated with significant findings on the 24-h CT scan. Only 2 of the 24 patients had an initial National Institutes of Health Stroke Scale score of < 7.
The 24-h head CT scan does not change management for most patients, particularly those with low National Institutes of Health Stroke Scale scores who do not undergo MT. Consideration should be given to removing routine follow-up imaging from postthrombolysis protocols in favor of an examination-based approach.
目前,大多数急性脑卒中治疗方案都包括在静脉组织型纤溶酶原激活物或机械取栓后进行 24 小时头颅 CT 扫描。然而,随着有关治疗并发症高危人群的证据不断出现,所有患者常规神经影像学检查的作用变得不太明确。
回顾 2004 年至 2018 年期间在约翰霍普金斯湾景医疗中心就诊并接受静脉组织型纤溶酶原激活物和/或机械取栓治疗的 475 例急性缺血性脑卒中患者的临床资料。评估患者入院 48 小时内的神经影像学检查结果,包括水肿、出血性转化(HT)或其他改变治疗方案的发现。将因神经功能恶化而行早期(<24 小时)影像检查与按方案(24±6 小时)进行的影像检查进行比较。确定与按方案行影像检查时发现有显著影像学和临床意义发现相关的因素。
153 例(32%)患者进行了早期影像检查,这些患者的卒中一般更严重。15%的患者发生 HT。对于其余 322 例患者(n=322),仅 24 例患者的 24 小时影像检查影响了急性期治疗:1 例(0.3%)患者需紧急行去骨瓣减压术,23 例(7.1%)患者需要进一步行影像检查以监测无症状性 HT 或水肿。高龄、较高的卒中严重程度、机械取栓和房颤与 24 小时 CT 扫描的显著发现相关。仅有 24 例患者的初始国立卫生研究院卒中量表评分<7。
对于大多数患者,特别是那些未接受机械取栓治疗且初始国立卫生研究院卒中量表评分较低的患者,24 小时头颅 CT 扫描不会改变治疗方案。在溶栓后治疗方案中,应考虑不再进行常规随访影像学检查,而采用基于体格检查的方法。